Stay updated on Duvelisib vs Ofatumumab in CLL/SLL Clinical Trial

Sign up to get notified when there's something new on the Duvelisib vs Ofatumumab in CLL/SLL Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Duvelisib vs Ofatumumab in CLL/SLL Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.5.4, replacing the previous v3.5.3. This indicates a minor update to the site's underlying system, with no visible changes to the study details.
    Difference
    0.1%
    Check dated 2026-05-14T23:09:07.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The page now shows the revision label as v3.5.3, indicating an updated build of the page.
    Difference
    0.0%
    Check dated 2026-04-30T15:33:50.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    The page revision indicator was updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-16T10:22:22.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    The location label 'Padua, Italy 35128' was updated to 'Padova, Italy 35128' in the locations list.
    Difference
    0.0%
    Check dated 2026-04-09T07:53:02.000Z thumbnail image
  7. Check
    51 days ago
    Change Detected
    Summary
    Added B-cell chronic lymphocytic leukemia as a disease term on the page. Included a resources section linking the Genetic and Rare Diseases Information Center.
    Difference
    0.1%
    Check dated 2026-04-02T00:11:01.000Z thumbnail image
  8. Check
    58 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.3 to v3.5.0 on the page.
    Difference
    0.0%
    Check dated 2026-03-25T20:13:13.000Z thumbnail image

Stay in the know with updates to Duvelisib vs Ofatumumab in CLL/SLL Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Duvelisib vs Ofatumumab in CLL/SLL Clinical Trial page.